Crescent Biopharma, Inc. (CBIO) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 195.56M | 236.66M | 134.56M | 154.23M | 5.99M | 11.09M | 15.65M | 23.86M | 33.27M | 43.79M | 52.01M | 60.37M | 68.09M | 50.71M | 53.85M | 61.26M | 77.46M | 90.79M | 104.13M | 120.31M |
| Cash & Short-Term Investments | 189.16M | 213.19M | 133.26M | 152.65M | 5.61M | 10.72M | 14.39M | 22.39M | 31.28M | 41.79M | 49.41M | 58.04M | 65M | 47.87M | 51.62M | 60.24M | 76.52M | 90.25M | 101.92M | 118.85M |
| Cash Only | 189.16M | 213.19M | 133.26M | 152.65M | 5.61M | 10.72M | 14.39M | 22.39M | 31.28M | 41.79M | 49.41M | 58.04M | 65M | 47.87M | 51.62M | 60.24M | 76.52M | 90.25M | 101.92M | 118.85M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 18M | 0 | 0 | 0 | 136.58K | 50.26K | 76.71K | 109.95K | 175.82K | 188.95K | 215.37K | 234.11K | 144.02K | 90.33K | 120.87K | 4.78K | 1.35K | 1.44K | 1.66K |
| Days Sales Outstanding | - | 152.71 | - | - | - | - | - | - | - | 1.68K | - | - | - | - | - | 76.22 | - | 7.28 | 1.65 | 142.98K |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.4M | 5.46M | 1.3M | 1.58M | 78.76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 3.57M | 3.64M | 3.71M | 3.21M | 0 | 0 | 52.32K | 561.31K | 937.52K | 1.53M | 1.19M | 1.45M | 835.12K | 1.1M | 2.11M | 3.78M | 4M | 3.56M | 3.81M | 4.06M |
| Property, Plant & Equipment | 2.3M | 2.31M | 2.35M | 1.8M | 0 | 0 | 0 | 424.21K | 598.26K | 767.83K | 1.09M | 1.35M | 732.8K | 751.17K | 1.25M | 1.51M | 1.73M | 1.95M | 2.2M | 2.45M |
| Fixed Asset Turnover | 0.45x | 4.65x | - | - | - | - | - | - | - | 0.01x | - | - | - | - | - | 0.05x | - | 0.01x | 0.04x | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 4.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 107K | 106K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.27M | 1.32M | -3.59M | 1.3M | 0 | 0 | 52.32K | 137.1K | 339.26K | 757.91K | 102.32K | 102.32K | 102.32K | 344.71K | 860.12K | 2.27M | 2.27M | 1.61M | 1.61M | 1.61M |
| Total Assets | 199.13M | 240.29M | 138.27M | 157.43M | 5.99M | 11.09M | 15.7M | 24.42M | 34.2M | 45.32M | 53.2M | 61.82M | 68.92M | 51.81M | 55.96M | 65.04M | 81.46M | 94.35M | 107.94M | 124.38M |
| Asset Turnover | 0.00x | 0.06x | - | - | - | - | - | - | - | 0.00x | - | - | - | - | - | 0.00x | - | 0.00x | 0.00x | 0.00x |
| Asset Growth % | 3223.16% | 2066.47% | 780.8% | 544.72% | -82.48% | -75.52% | -70.49% | -60.5% | -50.37% | -12.53% | -4.93% | -4.95% | -15.4% | -45.08% | -48.16% | -47.7% | -40.98% | -33.95% | -28.24% | -21.45% |
| Total Current Liabilities | 14.19M | 36.07M | 20.3M | 16.75M | 2.62M | 5.78M | 4.32M | 4.36M | 5.29M | 6.84M | 6.39M | 6.57M | 6.74M | 8.88M | 7.75M | 8.94M | 12.78M | 11.82M | 9.66M | 10.25M |
| Accounts Payable | 1.19M | 10M | 2.56M | 1.65M | 148.26K | 1.38M | 1.01M | 950.76K | 755.53K | 868.12K | 329.88K | 241.49K | 480.15K | 970.19K | 852.13K | 1.27M | 2.28M | 2.11M | 1.39M | 1.17M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 453K | 435K | 417K | 211K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 3.12M | 4.16M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 9.43M | 21.48M | 17.33M | 9.7M | 1.68M | 3.49M | 1.82M | 545.55K | 1.23M | 2.96M | 2.4M | 2.57M | 2M | 2.97M | 0 | 0 | 0 | 2.5M | 0 | 2.79M |
| Current Ratio | 13.78x | 6.56x | 6.63x | 9.21x | 2.29x | 1.92x | 3.62x | 5.48x | 6.28x | 6.41x | 8.14x | 9.19x | 10.10x | 5.71x | 6.95x | 6.85x | 6.06x | 7.68x | 10.78x | 11.74x |
| Quick Ratio | 13.78x | 6.56x | 6.63x | 9.21x | 2.29x | 1.92x | 3.62x | 5.48x | 6.28x | 6.41x | 8.14x | 9.19x | 10.10x | 5.71x | 6.95x | 6.85x | 6.06x | 7.68x | 10.78x | 11.74x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.09M | 1.21M | 1.32M | 1.43M | 0 | 0 | 0 | 0 | 0 | 66.84K | 262.13K | 448.77K | 0 | 0 | 95.61K | 378.79K | 651.79K | 918.61K | 1.72M | 1.84M |
| Long-Term Debt | 1.09M | 1.21M | 1.32M | 1.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 1.32M | 1.43M | 0 | 0 | 0 | 0 | 0 | 66.84K | 262.13K | 448.77K | 0 | 0 | 95.61K | 378.79K | 651.79K | 918.61K | 1.18M | 1.44M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | -1.32M | -1.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 538.59K | 408.32K |
| Total Liabilities | 15.28M | 37.28M | 21.63M | 18.18M | 2.62M | 5.78M | 4.32M | 4.36M | 5.29M | 6.9M | 6.65M | 7.02M | 6.74M | 8.88M | 7.84M | 9.32M | 13.43M | 12.74M | 11.38M | 12.09M |
| Total Debt | 1.54M | 1.64M | 3.06M | 3.08M | 0 | 66.84K | 262.13K | 448.77K | 630.83K | 808.4K | 1.01M | 1.27M | 651.73K | 918.55K | 1.18M | 1.43M | 1.68M | 1.92M | 2.15M | 2.38M |
| Net Debt | -187.62M | -211.55M | -130.2M | -149.57M | -5.61M | -10.65M | -14.13M | -21.94M | -30.65M | -40.98M | -48.4M | -56.77M | -64.35M | -46.95M | -50.44M | -58.81M | -74.84M | -88.33M | -99.77M | -116.47M |
| Debt / Equity | 0.01x | 0.01x | 0.03x | 0.02x | - | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x | 0.02x | 0.02x | 0.03x | 0.02x | 0.02x | 0.02x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | -19.31x | -12.62x | -19.97x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 183.85M | 203.01M | 116.64M | 139.25M | 3.38M | 5.31M | 11.38M | 20.06M | 28.91M | 38.41M | 46.55M | 54.8M | 62.18M | 42.93M | 48.12M | 55.73M | 68.03M | 81.6M | 96.57M | 112.29M |
| Equity Growth % | 5346.91% | 3720.64% | 925.3% | 594.1% | -88.33% | -86.17% | -75.56% | -63.39% | -53.51% | -10.52% | -3.26% | -1.66% | -8.6% | -47.39% | -50.17% | -50.37% | -45.63% | -36.36% | -30.16% | -22.96% |
| Book Value per Share | 6.05 | 10.06 | 7.05 | 36.10 | 0.17 | 0.27 | 0.18 | 0.31 | 0.45 | 0.60 | 0.72 | 0.85 | 1.03 | 0.81 | 0.92 | 1.06 | 1.30 | 1.57 | 1.87 | 2.18 |
| Total Shareholders' Equity | 183.85M | 203.01M | 116.64M | 139.25M | 3.38M | 5.31M | 11.38M | 20.06M | 28.91M | 38.41M | 46.55M | 54.8M | 62.18M | 42.93M | 48.12M | 55.73M | 68.03M | 81.6M | 96.57M | 112.29M |
| Common Stock | 28K | 28K | 14K | 14K | 64.53K | 64.48K | 64.48K | 64.48K | 64.45K | 64.39K | 64.37K | 64.31K | 64.25K | 54.38K | 52.42K | 52.42K | 52.39K | 52.31K | 51.74K | 51.54K |
| Retained Earnings | -195.09M | -171.81M | -79.41M | -54.8M | -496.71M | -494.36M | -487.14M | -477.32M | -467.22M | -456.49M | -447.41M | -438.2M | -429.95M | -419.59M | -409.34M | -400.82M | -387.55M | -372.9M | -355.48M | -338.14M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |